JUN and psoriasis: Knockout of c‐Jun or inhibition of its upstream molecule, JNK, significantly ameliorates IMQ‐induced psoriatic inflammation,27 suggesting JNK/c‐Jun axis as potential therapeutic targets for psoriasis.